Quarterly ResultAug 4, 2026, 06:37 AM
InfuSystem Q2 Net Revenue $36.9M; Net Income $3.2M
AI Summary
InfuSystem Holdings, Inc. reported strong financial results for the second quarter of 2026, with net revenues increasing 2.6% to $36.9 million and net income rising 23.1% to $3.2 million. Adjusted EBITDA grew 7.6% to $8.6 million, and the company's Adjusted EBITDA margin expanded to 23.4%. The company reaffirmed its full-year 2026 guidance for pro-forma revenue growth of 6% to 8% and mid to low 20s Adjusted EBITDA margin, driven by growth in Patient Services and improved profitability from a restructured GE Healthcare contract.
Key Highlights
- Net revenues increased 2.6% to $36.9 million for Q2 2026.
- Net income rose 23.1% to $3.2 million, or $0.15 per diluted share.
- Adjusted EBITDA grew 7.6% to $8.6 million, with margin expanding to 23.4%.
- Patient Services net revenue increased 15% to $24.8 million.
- Device Solutions net revenue decreased 16% to $12.1 million.
- Gross profit increased 7.7% to $21.4 million, with gross margin at 58%.
- The company repurchased $3.5 million in stock during the quarter.
- Reaffirmed full-year 2026 pro-forma revenue growth guidance of 6% to 8%.
Price Impact
More from INFU